ADI, the very name is a significant word from Indian scriptures denoting the initiator or the main one. Living up to its name, the group has recorded trailblazing success marking its strong presence in all the industries it has entered – IT/ITeS, Contract Research, Knowledge Processes, Bio-solutions, Web Solutions or even the latest one of Mobile Applications.
ADI Group envisioned to be an innovative start-up in services and consulting and started its operations in 1999. The key observation at the beginning was the reliability gap in the service industry. ADI focused on bridging the gap by nurturing its team with not only technical skills, but also inculcating integrity and reliability as a core value. ADI, while growing built a principle centric atmosphere for its people, and invoked the quest for excellence, quality and timely delivery, which helped our customer recognize the value we have delivered with every project undertaken.
Today, we are proud to have travelled a successful journey, for which we thank our team that readily took challenges, performed and lived up to our mission with thorough commitment, delivering excellence every single time. In our success, we give due credit to our clients who rested their faith in us, recognized our quest for excellence and helped us improvise.
Today, ADI Group has horizontal and vertical offerings for various industry segments. Our offerings help industry leaders and departments make faster decisions through are BUSINESS INTELLIGENCE services, reach out to their audience with our ANIMATION, allow their teams to be more productive quickly through our ELEARNING, get the best technology performance through our IT SERVICE, get the cutting edge of Data analytics through our BIG DATA technology, get the best of business focus and cost benefits with our PROCESS OUTSOURCING, get efficiency in drug development through our CLINICAL TRIAL SERVICES, and facilitate new drug development with our DRUG REPURPOSING services.
We aim at growing further while being the facilitators in our customer’s growth.
What started back then as a DBA entity with a small group of 7 team members has now expanded to a team of hundreds of expert professionals; ADI continues to transcend geographical limits to win over global associates. The group’s incredible growth rate, more than 50% p.a., reflects a lot about its leadership, the whole team’s dedication, and its commitment to excellence. Being a pioneer is what defines the company best; doing everything with utmost precision, and with ever-innovative approach is how the company redefines itself.
ADI holds an excellent record of client retention, which is what enables us to touch new pinnacles of success; the credit for this is humbly shared by its astute managerial team, proficient medical doctors and researchers, creative animators and designers, and innovative technical staff. No wonder, ADI group is reckoned worldwide as one of the finest in knowledge process outsourcing, new drug delivery processes, high end tools for drug development, and contract research and consultation.
Every day is a new challenge at ADI. Come and witness how the ADI team surmounts them.
Our vision is to foster each of our group companies from a startup to a leader in its domain. We endeavor to be celebrated for our values, quality and commitment, so that the name ADI Group echoes at par with values of trust and excellence.
At ADI, our mission statement reflects our principle centric approach and our quest for excellence in all our endeavors. Our aim is to –
-Leverage our passion and creativity to build great products and perfect solutions, thus leading to a quantifiable impact and bringing about a difference by providing significant cost-savings to our clients
– Build a culture of constant improvement, transparency, and fairness with all stakeholders
– Win global recognition for our work and our people
– Embrace responsibility and accountability for all our actions as we take pride in all that we do
– Make significant and sustainable contribution to the communities from where we operate
If ADI were an acronym, it would stand for the following values that are imbued deep in our work culture:
Accuracy – Even 99.99% won’t do at ADI. In winning trust, qualities of being precise and diligently responsible are quintessential.
Dedication – The group redefines dedication in practices such as meeting deadlines, project submissions and quality controls. Integrity and commitment is a way of life at ADI.
Innovation – The ability to convert ideas into solutions and surpassing the challenge of finding new ways of doing things the better way lies at the heart of ADI.
Following these core values, helps ADI successfully incorporate other values that together form the secret to our successful journey. These are:
Wisdom and Foresight defines Mr Singh; his half a century of entrepreneurial experience echoes how he used his discerning skills to set out on the path of worthy success. His enthusiastic and pulsating mind-set outmatches even the youngest managers. Reckoned as a man of ideas and ideals, Mr Singh leads from the front and sets high standards of business acumen without foregoing his philanthropic spirit.
Maneet Singh Matharu
An Idea catalyst and an exemplary leader, Mr Maneet stands tall with his 15 years of vast experience in Medical KPO, Clinical Research, Data Management, Turn-key Project Consulting and Telecommunication. His biggest strength lies in his profound understanding; discuss a problem with him and he justifies within minutes why the Industry has named him ‘The Solution person’. Believing leadership to be a synonym for action and not just position, Mr Maneet has mentored many a young minds. He continues to inspire the whole team by breaking down his extensive knowledge into easily digestible, clearer and simpler ideas.
Bernard, based in Paris-France is your dedicated contact to complete all your projects. Having worked in different companies, Admonya, TF1, Casino and Cora with missions in France and abroad, Bernard has a good knowledge of the business world and is an enthusiast entrepreneur. Extremely involved and professional, he will understand your business, your challenges and your environment before formalizing, with you, goals and strategies to be implemented to achieve your project and bring you a positive and personalized solution to your needs. His own philosophy could be: a human way of speaking, believing in technology, finding a creative approach, keeping it simple, curiosity about life, being passionate, creativity with quality, being trustworthy, nurturing good taste. Graduate of ESSEC Paris and ISC Paris, Bernard loves to learn new things every day.
James is an accomplished corporate leader with a proven track record of building and leading high-growth businesses. His experience spans almost 20 years of working across multiple business disciplines internationally, with a particular focus on converting information and analytics into plans that deliver profitable revenue growth against objectives. James’s deep knowledge of competitive and market intelligence applications makes him an ideal partner for clients seeking informed understanding of their market trends, opportunities and competitive issues. He has a proven ability to define and deliver change initiatives to build capability and transform processes to maximise returns from existing and new initiatives.
Member, Advisory Board
Ken Robinson, the founder of Magnentum, is a veteran of the world of pharmaceutical/medical documentation. In nearly 30 years of commitment to establishing and refining excellent work processes and creating highest quality documents he has mastered various roles, from writing most types of clinical regulatory documents to supervising the preparation of clinical documentation that meets global standards. Ken helped establish and direct writing groups at Sterling Winthrop, Sanofi, DuPont Merck, DuPont Pharmaceuticals, and Bristol-Myers Squibb. Since 2008 he has been President of Robinson RegDocs, Inc, writing clinical documents, and supervising and mentoring teams of writers. Ken is a thorough driver of efficiency and has a knack for tapping the best human potential, much of which reflects his hands-on experience in the teaching profession before venturing into the world of pharmaceuticals. Ken has utilized his skills in international settings, helping companies formulate and manage time saving plans for documentation and submissions. Trained in advanced writing, reviewing, and presentation techniques to meet the needs of health agency reviewers, he has written clinical study reports, Common Technical Document summaries, background documents for meetings with health authorities, investigator brochures, risk evaluation and management plans, pediatric investigation plans, safety updates, and responses to health authority questions.
Dr. Elisabeth Hervier
Member, Advisory Board
Dr Elisabeth Hervier is based in Paris, France and has been associated to Pharmaceutical industry since last 45 years. She is presently a mentor to a number of Pharmaceutical, consulting and service companies. Dr Elisabeth has been an avid entrepreneur and anchor for many pharmaceutical companies in France. She has been the president of Zydus in France and consultant to many others like Ranbaxy. Dr Hervier has been Vice-President of CCIP-Paris district-in charge of International Business & Paris development Agency. Dr. Hervier is Doctor of Pharmacy from University of Paris and is Expert in International Regulatory Affairs and Biotechnologies.
Dr. Christian Tidona
Member, Advisory Board
Dr Tidona is Managing Director of BioMedX & BioRN Clusture. Dr. Tidona studied biology and received his PhD from the University of Heidelberg, Germany. After ten years of experience in startup and leadership of biotech companies such as Multimetrix in Regensburg, Cytonet near Heidelberg, and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), he joined the Biotech Cluster Rhine‐Neckar (BioRN). Under his leadership, BioRN won the German Leading-Edge Cluster Competition 2008 and received a grant of 40 million Euro from the German federal government. At BioRN he co-founded the Health Axis Europe alliance between the European health innovation clusters in Cambridge, Leuven, and Heidelberg. He is member of the Responsible Leaders Impact Circle for Social Innovations of the BMW Foundation Herbert Quandt, and teaching entrepreneurship at the University of Heidelberg.
Dr. Prithipal Singh
Member, Advisory Board
Dr Prithipal Singh is based in the Silicon Valley, and is a pioneer in the medical devices arena. His last product was launched by President Bill Clinton at the White House. Dr. Prithipal holds over 40 US patents and over 200 worldwide. Dr Prithipal Singh currently serves on the Board of Directors of Abaxis, Inc. Dr. Prithal has been Vice President at Syntex Corporation, Executive Vice President of Idetec Corporation and a Vice President of Syva Corporation. After his years in the corporate world, Dr Singh turned entrepreneur and founded ChemTrak Inc (funded by Sequoia Capital) amongst other companies. He became the first Indian to take a Biomedical Company public on NASDAQ stock exchange in 1992. Dr Singh holds a Doctorate from the University of Toronto and did his Post doctorate from University of South Hampton.
Director, Vertical - IT
Hitting a success trajectory at young age, Mr. Franklin has been outperforming expectations as a fresher and now as a Vertical Head ─ IT. His passion and pursuit of organizational abilities brought him in ADI group in 2007; since then he has been giving his best overseeing the smooth running of services, support and project deliveries. An MBA by profession, he excels with his clarity of vision and commitment through action. He currently serves as an Vertical Head ─ IT Services (Dynaweb Private Limited).
Director, Vertical - Animaton
Neerja has been with us since 2007 and in that time has successfully delivered projects which involved complex trials clinical trial data assignments, and developed bespoke clinical trials solutions for a diverse array of clients. With five years experience working in the Central Nervous System (CNS) therapeutic area, she oversees projects which fall under this umbrella. Neerja holds a Masters in Biotech, and ensures medical writing teams, medical animation teams, and common technical document authors meet their deadlines.
Director, Vertical - BI & Clinical Trial Services.
It is not just because of her MBA degree in Human Resource Management that makes Ms Reena manage every single aspect relating to company personnel so amazingly, her dedication of doing right things and in right manner leads her to success. She has risen quickly through the ranks to be the Manager of Human Resource in ADI group due to her keen organizational instincts and proven ability to deliver bottom-line results.